Report Detail
Global Pharmacovigilance Software Market 2024 by Company, Regions, Type and Application, Forecast to 2030
- RnM3799931 |
- 13 August, 2024 |
- Global |
- 109 Pages |
- GIR (Global Info Research) |
- Service & Software
According to our (Global Info Research) latest study, the global Pharmacovigilance Software market size was valued at USD 176.6 million in 2023 and is forecast to a readjusted size of USD 258.7 million by 2030 with a CAGR of 5.6% during review period.
It manages all Adverse Events regarding drugs, devices, vaccines, biologics, cosmetics and nutritional supplements.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
The Global Info Research report includes an overview of the development of the Pharmacovigilance Software industry chain, the market status of Pharma & biotech companies (ADR Reporting, Drug Safety Audits), CROs (ADR Reporting, Drug Safety Audits), and key enterprises in developed and developing market, and analysed the cutting-edge technology, patent, hot applications and market trends of Pharmacovigilance Software.
Regionally, the report analyzes the Pharmacovigilance Software markets in key regions. North America and Europe are experiencing steady growth, driven by government initiatives and increasing consumer awareness. Asia-Pacific, particularly China, leads the global Pharmacovigilance Software market, with robust domestic demand, supportive policies, and a strong manufacturing base.
Key Features:
The report presents comprehensive understanding of the Pharmacovigilance Software market. It provides a holistic view of the industry, as well as detailed insights into individual components and stakeholders. The report analysis market dynamics, trends, challenges, and opportunities within the Pharmacovigilance Software industry.
The report involves analyzing the market at a macro level:
Market Sizing and Segmentation: Report collect data on the overall market size, including the revenue generated, and market share of different by Type (e.g., ADR Reporting, Drug Safety Audits).
Industry Analysis: Report analyse the broader industry trends, such as government policies and regulations, technological advancements, consumer preferences, and market dynamics. This analysis helps in understanding the key drivers and challenges influencing the Pharmacovigilance Software market.
Regional Analysis: The report involves examining the Pharmacovigilance Software market at a regional or national level. Report analyses regional factors such as government incentives, infrastructure development, economic conditions, and consumer behaviour to identify variations and opportunities within different markets.
Market Projections: Report covers the gathered data and analysis to make future projections and forecasts for the Pharmacovigilance Software market. This may include estimating market growth rates, predicting market demand, and identifying emerging trends.
The report also involves a more granular approach to Pharmacovigilance Software:
Company Analysis: Report covers individual Pharmacovigilance Software players, suppliers, and other relevant industry players. This analysis includes studying their financial performance, market positioning, product portfolios, partnerships, and strategies.
Consumer Analysis: Report covers data on consumer behaviour, preferences, and attitudes towards Pharmacovigilance Software This may involve surveys, interviews, and analysis of consumer reviews and feedback from different by Application (Pharma & biotech companies, CROs).
Technology Analysis: Report covers specific technologies relevant to Pharmacovigilance Software. It assesses the current state, advancements, and potential future developments in Pharmacovigilance Software areas.
Competitive Landscape: By analyzing individual companies, suppliers, and consumers, the report present insights into the competitive landscape of the Pharmacovigilance Software market. This analysis helps understand market share, competitive advantages, and potential areas for differentiation among industry players.
Market Validation: The report involves validating findings and projections through primary research, such as surveys, interviews, and focus groups.
Market Segmentation
Pharmacovigilance Software market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of value.
Market segment by Type
ADR Reporting
Drug Safety Audits
Issue Tracking
Fully Integrated Software
Market segment by Application
Pharma & biotech companies
CROs
BPOs
Others
Market segment by players, this report covers
United BioSource Corporation
Sparta Systems
Oracle Corporation
Ennov Solutions
Max Application
EXTEDO GmbH
AB Cube
Relsys
Online Business Applications
ArisGlobal
Market segment by regions, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia and Rest of Asia-Pacific)
South America (Brazil, Argentina and Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
The content of the study subjects, includes a total of 13 chapters:
Chapter 1, to describe Pharmacovigilance Software product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of Pharmacovigilance Software, with revenue, gross margin and global market share of Pharmacovigilance Software from 2019 to 2024.
Chapter 3, the Pharmacovigilance Software competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and application, with consumption value and growth rate by Type, application, from 2019 to 2030.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2019 to 2024.and Pharmacovigilance Software market forecast, by regions, type and application, with consumption value, from 2025 to 2030.
Chapter 11, market dynamics, drivers, restraints, trends and Porters Five Forces analysis.
Chapter 12, the key raw materials and key suppliers, and industry chain of Pharmacovigilance Software.
Chapter 13, to describe Pharmacovigilance Software research findings and conclusion.
1 Market Overview
- 1.1 Product Overview and Scope of Pharmacovigilance Software
- 1.2 Market Estimation Caveats and Base Year
- 1.3 Classification of Pharmacovigilance Software by Type
- 1.3.1 Overview: Global Pharmacovigilance Software Market Size by Type: 2019 Versus 2023 Versus 2030
- 1.3.2 Global Pharmacovigilance Software Consumption Value Market Share by Type in 2023
- 1.3.3 ADR Reporting
- 1.3.4 Drug Safety Audits
- 1.3.5 Issue Tracking
- 1.3.6 Fully Integrated Software
- 1.4 Global Pharmacovigilance Software Market by Application
- 1.4.1 Overview: Global Pharmacovigilance Software Market Size by Application: 2019 Versus 2023 Versus 2030
- 1.4.2 Pharma & biotech companies
- 1.4.3 CROs
- 1.4.4 BPOs
- 1.4.5 Others
- 1.5 Global Pharmacovigilance Software Market Size & Forecast
- 1.6 Global Pharmacovigilance Software Market Size and Forecast by Region
- 1.6.1 Global Pharmacovigilance Software Market Size by Region: 2019 VS 2023 VS 2030
- 1.6.2 Global Pharmacovigilance Software Market Size by Region, (2019-2030)
- 1.6.3 North America Pharmacovigilance Software Market Size and Prospect (2019-2030)
- 1.6.4 Europe Pharmacovigilance Software Market Size and Prospect (2019-2030)
- 1.6.5 Asia-Pacific Pharmacovigilance Software Market Size and Prospect (2019-2030)
- 1.6.6 South America Pharmacovigilance Software Market Size and Prospect (2019-2030)
- 1.6.7 Middle East and Africa Pharmacovigilance Software Market Size and Prospect (2019-2030)
2 Company Profiles
- 2.1 United BioSource Corporation
- 2.1.1 United BioSource Corporation Details
- 2.1.2 United BioSource Corporation Major Business
- 2.1.3 United BioSource Corporation Pharmacovigilance Software Product and Solutions
- 2.1.4 United BioSource Corporation Pharmacovigilance Software Revenue, Gross Margin and Market Share (2019-2024)
- 2.1.5 United BioSource Corporation Recent Developments and Future Plans
- 2.2 Sparta Systems
- 2.2.1 Sparta Systems Details
- 2.2.2 Sparta Systems Major Business
- 2.2.3 Sparta Systems Pharmacovigilance Software Product and Solutions
- 2.2.4 Sparta Systems Pharmacovigilance Software Revenue, Gross Margin and Market Share (2019-2024)
- 2.2.5 Sparta Systems Recent Developments and Future Plans
- 2.3 Oracle Corporation
- 2.3.1 Oracle Corporation Details
- 2.3.2 Oracle Corporation Major Business
- 2.3.3 Oracle Corporation Pharmacovigilance Software Product and Solutions
- 2.3.4 Oracle Corporation Pharmacovigilance Software Revenue, Gross Margin and Market Share (2019-2024)
- 2.3.5 Oracle Corporation Recent Developments and Future Plans
- 2.4 Ennov Solutions
- 2.4.1 Ennov Solutions Details
- 2.4.2 Ennov Solutions Major Business
- 2.4.3 Ennov Solutions Pharmacovigilance Software Product and Solutions
- 2.4.4 Ennov Solutions Pharmacovigilance Software Revenue, Gross Margin and Market Share (2019-2024)
- 2.4.5 Ennov Solutions Recent Developments and Future Plans
- 2.5 Max Application
- 2.5.1 Max Application Details
- 2.5.2 Max Application Major Business
- 2.5.3 Max Application Pharmacovigilance Software Product and Solutions
- 2.5.4 Max Application Pharmacovigilance Software Revenue, Gross Margin and Market Share (2019-2024)
- 2.5.5 Max Application Recent Developments and Future Plans
- 2.6 EXTEDO GmbH
- 2.6.1 EXTEDO GmbH Details
- 2.6.2 EXTEDO GmbH Major Business
- 2.6.3 EXTEDO GmbH Pharmacovigilance Software Product and Solutions
- 2.6.4 EXTEDO GmbH Pharmacovigilance Software Revenue, Gross Margin and Market Share (2019-2024)
- 2.6.5 EXTEDO GmbH Recent Developments and Future Plans
- 2.7 AB Cube
- 2.7.1 AB Cube Details
- 2.7.2 AB Cube Major Business
- 2.7.3 AB Cube Pharmacovigilance Software Product and Solutions
- 2.7.4 AB Cube Pharmacovigilance Software Revenue, Gross Margin and Market Share (2019-2024)
- 2.7.5 AB Cube Recent Developments and Future Plans
- 2.8 Relsys
- 2.8.1 Relsys Details
- 2.8.2 Relsys Major Business
- 2.8.3 Relsys Pharmacovigilance Software Product and Solutions
- 2.8.4 Relsys Pharmacovigilance Software Revenue, Gross Margin and Market Share (2019-2024)
- 2.8.5 Relsys Recent Developments and Future Plans
- 2.9 Online Business Applications
- 2.9.1 Online Business Applications Details
- 2.9.2 Online Business Applications Major Business
- 2.9.3 Online Business Applications Pharmacovigilance Software Product and Solutions
- 2.9.4 Online Business Applications Pharmacovigilance Software Revenue, Gross Margin and Market Share (2019-2024)
- 2.9.5 Online Business Applications Recent Developments and Future Plans
- 2.10 ArisGlobal
- 2.10.1 ArisGlobal Details
- 2.10.2 ArisGlobal Major Business
- 2.10.3 ArisGlobal Pharmacovigilance Software Product and Solutions
- 2.10.4 ArisGlobal Pharmacovigilance Software Revenue, Gross Margin and Market Share (2019-2024)
- 2.10.5 ArisGlobal Recent Developments and Future Plans
3 Market Competition, by Players
- 3.1 Global Pharmacovigilance Software Revenue and Share by Players (2019-2024)
- 3.2 Market Share Analysis (2023)
- 3.2.1 Market Share of Pharmacovigilance Software by Company Revenue
- 3.2.2 Top 3 Pharmacovigilance Software Players Market Share in 2023
- 3.2.3 Top 6 Pharmacovigilance Software Players Market Share in 2023
- 3.3 Pharmacovigilance Software Market: Overall Company Footprint Analysis
- 3.3.1 Pharmacovigilance Software Market: Region Footprint
- 3.3.2 Pharmacovigilance Software Market: Company Product Type Footprint
- 3.3.3 Pharmacovigilance Software Market: Company Product Application Footprint
- 3.4 New Market Entrants and Barriers to Market Entry
- 3.5 Mergers, Acquisition, Agreements, and Collaborations
4 Market Size Segment by Type
- 4.1 Global Pharmacovigilance Software Consumption Value and Market Share by Type (2019-2024)
- 4.2 Global Pharmacovigilance Software Market Forecast by Type (2025-2030)
5 Market Size Segment by Application
- 5.1 Global Pharmacovigilance Software Consumption Value Market Share by Application (2019-2024)
- 5.2 Global Pharmacovigilance Software Market Forecast by Application (2025-2030)
6 North America
- 6.1 North America Pharmacovigilance Software Consumption Value by Type (2019-2030)
- 6.2 North America Pharmacovigilance Software Consumption Value by Application (2019-2030)
- 6.3 North America Pharmacovigilance Software Market Size by Country
- 6.3.1 North America Pharmacovigilance Software Consumption Value by Country (2019-2030)
- 6.3.2 United States Pharmacovigilance Software Market Size and Forecast (2019-2030)
- 6.3.3 Canada Pharmacovigilance Software Market Size and Forecast (2019-2030)
- 6.3.4 Mexico Pharmacovigilance Software Market Size and Forecast (2019-2030)
7 Europe
- 7.1 Europe Pharmacovigilance Software Consumption Value by Type (2019-2030)
- 7.2 Europe Pharmacovigilance Software Consumption Value by Application (2019-2030)
- 7.3 Europe Pharmacovigilance Software Market Size by Country
- 7.3.1 Europe Pharmacovigilance Software Consumption Value by Country (2019-2030)
- 7.3.2 Germany Pharmacovigilance Software Market Size and Forecast (2019-2030)
- 7.3.3 France Pharmacovigilance Software Market Size and Forecast (2019-2030)
- 7.3.4 United Kingdom Pharmacovigilance Software Market Size and Forecast (2019-2030)
- 7.3.5 Russia Pharmacovigilance Software Market Size and Forecast (2019-2030)
- 7.3.6 Italy Pharmacovigilance Software Market Size and Forecast (2019-2030)
8 Asia-Pacific
- 8.1 Asia-Pacific Pharmacovigilance Software Consumption Value by Type (2019-2030)
- 8.2 Asia-Pacific Pharmacovigilance Software Consumption Value by Application (2019-2030)
- 8.3 Asia-Pacific Pharmacovigilance Software Market Size by Region
- 8.3.1 Asia-Pacific Pharmacovigilance Software Consumption Value by Region (2019-2030)
- 8.3.2 China Pharmacovigilance Software Market Size and Forecast (2019-2030)
- 8.3.3 Japan Pharmacovigilance Software Market Size and Forecast (2019-2030)
- 8.3.4 South Korea Pharmacovigilance Software Market Size and Forecast (2019-2030)
- 8.3.5 India Pharmacovigilance Software Market Size and Forecast (2019-2030)
- 8.3.6 Southeast Asia Pharmacovigilance Software Market Size and Forecast (2019-2030)
- 8.3.7 Australia Pharmacovigilance Software Market Size and Forecast (2019-2030)
9 South America
- 9.1 South America Pharmacovigilance Software Consumption Value by Type (2019-2030)
- 9.2 South America Pharmacovigilance Software Consumption Value by Application (2019-2030)
- 9.3 South America Pharmacovigilance Software Market Size by Country
- 9.3.1 South America Pharmacovigilance Software Consumption Value by Country (2019-2030)
- 9.3.2 Brazil Pharmacovigilance Software Market Size and Forecast (2019-2030)
- 9.3.3 Argentina Pharmacovigilance Software Market Size and Forecast (2019-2030)
10 Middle East & Africa
- 10.1 Middle East & Africa Pharmacovigilance Software Consumption Value by Type (2019-2030)
- 10.2 Middle East & Africa Pharmacovigilance Software Consumption Value by Application (2019-2030)
- 10.3 Middle East & Africa Pharmacovigilance Software Market Size by Country
- 10.3.1 Middle East & Africa Pharmacovigilance Software Consumption Value by Country (2019-2030)
- 10.3.2 Turkey Pharmacovigilance Software Market Size and Forecast (2019-2030)
- 10.3.3 Saudi Arabia Pharmacovigilance Software Market Size and Forecast (2019-2030)
- 10.3.4 UAE Pharmacovigilance Software Market Size and Forecast (2019-2030)
11 Market Dynamics
- 11.1 Pharmacovigilance Software Market Drivers
- 11.2 Pharmacovigilance Software Market Restraints
- 11.3 Pharmacovigilance Software Trends Analysis
- 11.4 Porters Five Forces Analysis
- 11.4.1 Threat of New Entrants
- 11.4.2 Bargaining Power of Suppliers
- 11.4.3 Bargaining Power of Buyers
- 11.4.4 Threat of Substitutes
- 11.4.5 Competitive Rivalry
12 Industry Chain Analysis
- 12.1 Pharmacovigilance Software Industry Chain
- 12.2 Pharmacovigilance Software Upstream Analysis
- 12.3 Pharmacovigilance Software Midstream Analysis
- 12.4 Pharmacovigilance Software Downstream Analysis
13 Research Findings and Conclusion
14 Appendix
- 14.1 Methodology
- 14.2 Research Process and Data Source
Summary:
Get latest Market Research Reports on Pharmacovigilance Software. Industry analysis & Market Report on Pharmacovigilance Software is a syndicated market report, published as Global Pharmacovigilance Software Market 2024 by Company, Regions, Type and Application, Forecast to 2030. It is complete Research Study and Industry Analysis of Pharmacovigilance Software market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
